Cambridge Investment Research Advisors
BSX icon

Cambridge Investment Research Advisors’s Boston Scientific BSX Stock Holding History

Cambridge Investment Research Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.18M Sell
51,066
-2,757
-5% -$150K ﹤0.01% 1618
2026
Q1 		$3.38M Sell
53,823
-10,542
-16% -$843K 0.01% 1212
2025
Q4 		$6.14M Sell
64,365
-10,656
-14% -$1.04M 0.02% 810
2025
Q3 		$7.32M Buy
75,021
+21,091
+39% +$2.18M 0.02% 710
2025
Q2 		$5.79M Buy
53,930
+5,731
+12% +$580K 0.02% 775
2025
Q1 		$4.86M Sell
48,199
-114
-0.2% -$11.5K 0.02% 823
2024
Q4 		$4.32M Buy
48,313
+10,504
+28% +$925K 0.01% 885
2024
Q3 		$3.17M Sell
37,809
-6,141
-14% -$484K 0.01% 1051
2024
Q2 		$3.38M Buy
43,950
+3,242
+8% +$237K 0.01% 966
2024
Q1 		$2.79M Buy
40,708
+7,326
+22% +$471K 0.01% 1071
2023
Q4 		$1.93M Sell
33,382
-9,224
-22% -$492K 0.01% 1222
2023
Q3 		$2.25M Buy
42,606
+8,766
+26% +$460K 0.01% 1057
2023
Q2 		$1.83M Buy
33,840
+5,943
+21% +$310K 0.01% 1226
2023
Q1 		$1.4M Sell
27,897
-1,171
-4% -$55.2K 0.01% 1354
2022
Q4 		$1.34M Sell
29,068
-14,202
-33% -$615K 0.01% 1313
2022
Q3 		$1.68M Sell
43,270
-64,059
-60% -$2.57M 0.01% 1136
2022
Q2 		$4M Buy
107,329
+82,176
+327% +$3.35M 0.02% 685
2022
Q1 		$1.11M Buy
25,153
+77
+0.3% +$3.34K 0.01% 1494
2021
Q4 		$1.06M Buy
25,076
+918
+4% +$38.6K ﹤0.01% 1534
2021
Q3 		$1.05M Sell
24,158
-442
-2% -$19.6K 0.01% 1477
2021
Q2 		$1.05M Sell
24,600
-1,324
-5% -$55.7K 0.01% 1496
2021
Q1 		$1M Sell
25,924
-1,932
-7% -$73.1K 0.01% 1431
2020
Q4 		$1M Sell
27,856
-796
-3% -$28.7K 0.01% 1298
2020
Q3 		$1.09M Buy
28,652
+2,203
+8% +$84.9K 0.01% 1137
2020
Q2 		$929K Buy
26,449
+3,186
+14% +$115K 0.01% 1160
2020
Q1 		$759K Sell
23,263
-10,985
-32% -$429K 0.01% 1123
2019
Q4 		$1.55M Buy
34,248
+658
+2% +$27.5K 0.01% 916
2019
Q3 		$1.37M Buy
33,590
+471
+1% +$20K 0.01% 912
2019
Q2 		$1.42M Sell
33,119
-3,340
-9% -$128K 0.01% 862
2019
Q1 		$1.4M Buy
36,459
+1,385
+4% +$52.9K 0.01% 870
2018
Q4 		$1.24M Buy
35,074
+6,744
+24% +$245K 0.01% 830
2018
Q3 		$1.09M Sell
28,330
-1,095
-4% -$38.2K 0.01% 976
2018
Q2 		$962K Buy
29,425
+1,157
+4% +$34.9K 0.01% 1002
2018
Q1 		$772K Buy
28,268
+1,359
+5% +$36.9K 0.01% 1084
2017
Q4 		$667K Sell
26,909
-1,074
-4% -$29.6K 0.01% 1141
2017
Q3 		$816K Buy
27,983
+1,562
+6% +$43.1K 0.01% 943
2017
Q2 		$732K Sell
26,421
-1,072
-4% -$28.5K 0.01% 976
2017
Q1 		$684K Sell
27,493
-21,003
-43% -$511K 0.01% 918
2016
Q4 		$1.05M Buy
48,496
+2,926
+6% +$63.8K 0.02% 652
2016
Q3 		$1.08M Buy
45,570
+102
+0.2% +$2.43K 0.02% 648
2016
Q2 		$1.06M Buy
45,468
+23,199
+104% +$502K 0.02% 580
2016
Q1 		$419K Buy
22,269
+3,680
+20% +$64.6K 0.01% 990
2015
Q4 		$343K Buy
18,589
+1,268
+7% +$22.7K 0.01% 1073
2015
Q3 		$284K Sell
17,321
-3,103
-15% -$53K 0.01% 1049
2015
Q2 		$362K Buy
20,424
+1,255
+7% +$22.4K 0.01% 966
2015
Q1 		$340K Sell
19,169
-2,221
-10% -$35.1K 0.01% 996
2014
Q4 		$283K Buy
21,390
+523
+3% +$6.69K 0.01% 1038
2014
Q3 		$246K Buy
20,867
+3,138
+18% +$39.5K 0.01% 1198
2014
Q2 		$226K Buy
17,729
+960
+6% +$12.5K 0.01% 1140
2014
Q1 		$227K Buy
16,769
+5,504
+49% +$72.2K 0.01% 1099
2013
Q4 		$135K Buy
11,265
+530
+5% +$6.26K 0.01% 1147
2013
Q3 		$126K Sell
10,735
-5,000
-32% -$54.1K 0.01% 1111
2013
Q2 		$146K Buy
+15,735
New +$133K 0.01% 1015

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Cambridge Investment Research Advisors's BSX Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Boston Scientific (BSX) stake by 5.1% in Q2 2026, selling an estimated $150K and leaving 51,066 shares worth $2.18M. The position accounts for ﹤0.01% of the portfolio, ranked #1618.

Cambridge Investment Research Advisors first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.32M in Q3 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Cambridge Investment Research Advisors held 51,066 shares of Boston Scientific worth $2.18M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 2,757 Boston Scientific shares in Q2 2026, an estimated $150K.
  • Boston Scientific made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1618 holding.
  • Cambridge Investment Research Advisors first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
  • Cambridge Investment Research Advisors's Boston Scientific position peaked at $7.32M in Q3 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.